富含血小板的纤维素在XA因子抑制剂下切除单一牙后确保血静 - - 这是一项临床前性随机分口研究
Solomiya Kyyak1, Ali Jari2, Diana Heimes2
1Department of Oral and Maxillofacial Surgery, University Medical Center Mainz, Augustusplatz 2, 55131, Mainz, Germany. solomiya.kyyak@unimedizin-mainz.de.
Clinical oral investigations
|October 21, 2023
概括
富含血小板纤维素 (PRF) 和静血凝海绵 (GS) 在服用Xa因子 (FXa) 抑制剂的患者中有效控制拔牙后的出血. 停止使用FXa抑制剂是不必要的单一的牙去除.
科学领域:
- 在口腔外科手术.
- 血液学 血液学 血液学
- 生物材料是一种生物材料.
背景情况:
- 服用Xa因子 (FXa) 抑制剂的患者需要在拔牙过程中谨慎管理,以防止出血.
- 停止口服抗凝剂治疗 (OAT) 会增加血栓栓塞的风险.
研究的目的:
- 为了比较富血小板纤维素 (PRF) 与血静凝海绵 (GS) 在FXa抑制剂患者的提取插座中的血静效果.
- 为了评估PRF和GS的安全性,没有OAT撤销.
主要方法:
- 对21名患者 (42颗牙) 进行前性,双盲,随机分口研究.
- 提取插座被填充了PRF或GS.
- 抽取后立即评估出血,并在24小时7天后评估出血.
主要成果:
- 无论是PRF还是GS都显示出可靠的血液静止.
- 在PRF和GS组之间,出血事件没有显著差异.
- 在服用里瓦洛克萨班,阿皮克萨班或埃多克萨班的患者中没有观察到显著差异.
结论:
- 富含血小板纤维素 (PRF) 和静血凝海绵 (GS) 是FXa抑制剂患者在抽取后插座中的有效静血剂.
- 不需要停止FXa抑制剂单一牙的提取,减轻血栓形成的风险.
相关概念视频
Clot Retraction and Fibrinolysis
6.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.3K
Formation of the Platelet Plug
6.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
Introduction to Hemostasis
8.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.1K
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Extrinsic and Intrinsic Pathways of Hemostasis
8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K


